A β-delayed particle decay beam like 9C has been recognized as a double irradiation source, i.e. the external beam radiation itself and the delayed low-energy particles emitted internally. A radioactive 9C-ion beam, ...A β-delayed particle decay beam like 9C has been recognized as a double irradiation source, i.e. the external beam radiation itself and the delayed low-energy particles emitted internally. A radioactive 9C-ion beam, therefore, is considered to be very useful in cancer radiation therapy. To explore the potential importance of radioactive 9C-ion beams in cancer therapy, radiobiological experiments using a 9C beam supplied by the secondary beam line (SBL) at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan were carried out.展开更多
It is generally believed that there is no dose-rate sparing effect for mammalian cells exposed to high-LET heavy ion beams. To clarify this ambiguity, human salivary gland (HSG) cells were irradiated with carbon ion b...It is generally believed that there is no dose-rate sparing effect for mammalian cells exposed to high-LET heavy ion beams. To clarify this ambiguity, human salivary gland (HSG) cells were irradiated with carbon ion beams supplied by the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan at a low dose rate of 0.展开更多
文摘A β-delayed particle decay beam like 9C has been recognized as a double irradiation source, i.e. the external beam radiation itself and the delayed low-energy particles emitted internally. A radioactive 9C-ion beam, therefore, is considered to be very useful in cancer radiation therapy. To explore the potential importance of radioactive 9C-ion beams in cancer therapy, radiobiological experiments using a 9C beam supplied by the secondary beam line (SBL) at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan were carried out.
文摘It is generally believed that there is no dose-rate sparing effect for mammalian cells exposed to high-LET heavy ion beams. To clarify this ambiguity, human salivary gland (HSG) cells were irradiated with carbon ion beams supplied by the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan at a low dose rate of 0.
